Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 5.308
Filtrer
1.
J Cancer Res Clin Oncol ; 150(8): 399, 2024 Aug 24.
Article de Anglais | MEDLINE | ID: mdl-39180548

RÉSUMÉ

PURPOSE: This study explored the association between triglyceride-glucose (TyG), TyG index with body mass index (TyG-BMI), triglyceride/high-density lipoprotein cholesterol ratio (TG/HDL-C), metabolic score for insulin resistance (IR) (METS-IR) and the risk of esophageal cancer. METHODS: A total of 388,900 participants from the United Kingdom Biobank from 2006 to 2010 were included. Fine-Gray models, restricted cubic spline (RCS), and receiver operating characteristic (ROC) curves were used to assess the association between the four IR surrogates and the risk of esophageal cancer, specifically, esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC). RESULTS: Ten years after recruitment, 0.16% (95%CI 0.11-0.26%) had esophageal cancer and 4.17% (95%CI 3.86-4.46%) are deceased. For each standard deviation increase in the TyG index, TyG-BMI, TG/HDL-C, and METS-IR, the risk of EAC increased by Hazard ratios (HR)1.16, 1.37, 1.08, and 1.36, respectively (all P < 0.05), while the risk of ESCC decreased by HRs 0.80, 0.67, 0.77, and 0.65, respectively. RCS analysis indicated that most relationships were nonlinear (P < 0.05). ROC curves showed that METS-IR had a more robust diagnostic efficacy than TyG, TyG-BMI, and TG/HDL-C. CONCLUSION: TyG index, TyG-BMI, TG/HDL-C, and METS-IR were closely associated with the risk of EAC and ESCC. Additionally, METS-IR surpassed the other three IR indices in predicting and diagnosing the risks of EAC and ESCC. The METS-IR is expected to become a more effective metric for identifying populations at early risk of esophageal cancer and for improving risk stratification.


Sujet(s)
Biobanques , Tumeurs de l'oesophage , Insulinorésistance , Humains , Tumeurs de l'oesophage/épidémiologie , Tumeurs de l'oesophage/sang , Mâle , Femelle , Adulte d'âge moyen , Royaume-Uni/épidémiologie , Études prospectives , Facteurs de risque , Glycémie/analyse , Triglycéride/sang , Sujet âgé , Adénocarcinome/épidémiologie , Adénocarcinome/sang , Adénocarcinome/étiologie , Indice de masse corporelle , Carcinome épidermoïde de l'oesophage/épidémiologie , Carcinome épidermoïde de l'oesophage/sang , Adulte , Cholestérol HDL/sang ,
2.
Ann Acad Med Singap ; 53(7): 420-434, 2024 Jul 30.
Article de Anglais | MEDLINE | ID: mdl-39132959

RÉSUMÉ

Introduction: Alcohol flushing syndrome (AFS) is experienced by up to 46% of East Asians. This study aimed to review the risk of cancers in AFS patients, elucidate an exposure-response relationship, and understand risk associated with alcohol intake and cancer. Method: An electronic database search of PubMed, Embase, Scopus and Cochrane Library was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines. Observational studies on AFS' effects and all cancers risk were included. Studies including patients with existing malignancy were excluded. Dichotomous variables were pooled using the Mantel-Haenszel method with a random effects model. Sensitivity and subgroup analyses were performed. PROSPERO (CRD42023392916) protocol was followed. Results: A total of 18 articles were included in the final analysis with a total of 387,521 participants. AFS was associated with an increased risk of all cancers (odds ratio [OR] 1.19, 95% confidence interval [CI] 1.06-1.34), esophageal squamous cell carcinoma (OR 1.47, 95% CI 1.05-2.05) and gastric adenocarci-noma (OR 1.40, 95% CI 1.14-1.72). Men with AFS exhibited an increased risk of all cancers (OR 1.34, 95% CI 1.13-1.59). However, this was not observed in women. All cancers risk was associated with AFS in those who consumed drink (i.e. consumed alcohol) more than 200 g of pure ethanol/week (OR 1.68, 95% CI 1.20-2.37) but not those who consumed less than 200 g of pure ethanol/week (OR 1.27, 95% CI 0.90-1.79) or non-drinkers (OR 0.99, 95% CI 0.67-1.47). Conclusion: AFS is associated with an increased risk of all cancers, particularly esophageal squamous cell carcinoma and gastric adenocarcinoma.


Sujet(s)
Consommation d'alcool , Tumeurs de l'oesophage , Rougeur de la face , Humains , Rougeur de la face/épidémiologie , Tumeurs de l'oesophage/épidémiologie , Tumeurs de l'oesophage/étiologie , Consommation d'alcool/effets indésirables , Consommation d'alcool/épidémiologie , Tumeurs/épidémiologie , Tumeurs/étiologie , Carcinome épidermoïde de l'oesophage/épidémiologie , Carcinome épidermoïde de l'oesophage/étiologie , Tumeurs de l'estomac/épidémiologie , Tumeurs de l'estomac/étiologie , Adénocarcinome/épidémiologie , Adénocarcinome/étiologie , Facteurs de risque
3.
Expert Rev Gastroenterol Hepatol ; 18(8): 407-420, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-39072626

RÉSUMÉ

INTRODUCTION: Over the past several decades, Europe and the United States have experienced a rapid increase in esophageal adenocarcinoma. Research and countermeasures against Barrett's esophagus, its precancerous lesion, are progressing. Because esophageal adenocarcinoma has an extremely poor prognosis when diagnosed in an advanced stage, recommendations for early cancer detection have been made based on the various proven etiological factors of Barrett's esophagus and the actual cancer risk of Barrett's esophagus. In recent years, there have been indications of an increase in esophageal adenocarcinoma in Japan, and a similar trend of cancer will occur shortly in other Asian countries. Consequently, Asian countries must implement similar countermeasures against Barrett's esophagus and esophageal adenocarcinoma, referencing the knowledge gained thus far in Europe and the United States. AREAS COVERED: This review summarizes the latest findings on the etiologic factors of Barrett's esophagus and discusses the differences between Westerners and Asians. The current status of Barrett's esophagus in Japan and other Asian countries is also summarized. EXPERT OPINION: The etiological factors and cancer incidence of Barrett's esophagus in Asia diverge somewhat from those observed in Europe and America. Therefore, it is imperative to implement measures that are tailored to the actual circumstances of Asian people.


Sujet(s)
Adénocarcinome , Oesophage de Barrett , Tumeurs de l'oesophage , Oesophage de Barrett/épidémiologie , Oesophage de Barrett/étiologie , Humains , Tumeurs de l'oesophage/épidémiologie , Tumeurs de l'oesophage/étiologie , Tumeurs de l'oesophage/prévention et contrôle , Facteurs de risque , Adénocarcinome/épidémiologie , Adénocarcinome/étiologie , Adénocarcinome/prévention et contrôle , Asie/épidémiologie , Incidence , Asiatiques , États précancéreux/épidémiologie
4.
Int. j. morphol ; 42(2): 234-238, abr. 2024.
Article de Anglais | LILACS | ID: biblio-1558132

RÉSUMÉ

SUMMARY: Barrett's esophagus is a condition where the distal third of the esophagus changes its epithelial lining from non- keratinized stratified squamous to simple columnar. This cross-sectional descriptive study was conducted to characterize the esophageal mucosa in the third trimester of pregnancy and determine possible variants in its development and was carried out in the Morphology Laboratory of the Health Faculty of the Industrial University of Santander, Colombia, with 45 human fetuses in the third trimester of gestation (weeks 25-40). A section of the distal esophagus and the first portion of the cardial region of the stomach were obtained, and the histological sections were subjected to a fixation process with 5 % formaldehyde solution. The sections were stained with hematoxylin and eosin and were evaluated for the presence of epithelial change or glands in the esophageal lamina propria. The change from non- keratinized stratified squamous epithelium to simple columnar epithelium was observed in the esophageal mucosa in five fetuses (11.1 %). In 15 cases (33.3 %), the presence of mucous glands underlying the epithelium was determined. In two fetuses, simple columnar epithelium was observed in the esophageal mucosa and underlying submucosal glands (4.4 %). The lack of replacement of the columnar epithelium by squamous epithelium in the distal third of the esophagus and the presence of mucous glands in the last third of gestation may suggest the presentation of Barret's esophagus in adulthood and thus, a predisposition to develop esophageal adenocarcinoma.


El esófago de Barrett es una afección en la que el tercio distal del esófago cambia su revestimiento epitelial de escamoso estratificado no queratinizado a columnar simple. Este estudio descriptivo de corte transversal tiene como objetivo caracterizar la mucosa esofágica en el tercer trimestre del embarazo y determinar posibles variantes en su desarrollo y se realizó en el laboratorio de Morfología de la Facultad de Salud de la Universidad Industrial de Santander-Colombia, con 45 fetos humanos en el tercer trimestre de gestación (semanas 25-40). Se obtuvo una sección del esófago distal y la primera porción de la región cardial del estómago y las secciones histológicas se sometieron a un proceso de fijación con solución de formaldehído al 5 %. Los cortes se tiñeron con hematoxilina y eosina y se evaluaron determinando la presencia de cambio epitelial y glándulas en la lámina propia del esófago. El cambio de epitelio escamoso estratificado no queratinizado a epitelio cilíndrico simple se observó en la mucosa esofágica en cinco fetos (11,1 %). En 15 casos (33,3 %) se determinó la presencia de glándulas mucosas subyacentes al epitelio. En dos fetos se observó epitelio cilíndrico simple en la mucosa esofágica y glándulas submucosas subyacentes (4,4 %). La falta de reemplazo del epitelio cilíndrico por epitelio escamoso en el tercio distal del esófago y la presencia de glándulas mucosas en el último tercio de la gestación pueden sugerir la presentación de esófago de Barrett en la edad adulta y una predisposición a desarrollar adenocarcinoma de esófago.


Sujet(s)
Humains , Oesophage de Barrett/étiologie , Muqueuse oesophagienne/anatomopathologie , Oesophage de Barrett/complications , Tumeurs de l'oesophage/étiologie , Adénocarcinome/étiologie , Études transversales , Épithélium/anatomopathologie , Foetus , Métaplasie/anatomopathologie
5.
Surg Clin North Am ; 104(3): 673-684, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38677829

RÉSUMÉ

Inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (colorectal adenocarcinoma [CRC]) compared with the general population. IBD-related CRC is related to poorer outcomes than non-IBD-related CRC, and it accounts for 10% to 15% of death in patients with IBD. As such, screening guidelines have been made specific to this population recommending shorter intervals of endoscopic screening to detect dysplasia and CRC relative to the general population. Advances in endoscopic technology allow for improved visualization of dysplasia, which has led to widespread adoption of dye-spray chromoendoscopy with targeted biopsy.


Sujet(s)
Coloscopie , Tumeurs colorectales , Maladies inflammatoires intestinales , Humains , Tumeurs colorectales/diagnostic , Tumeurs colorectales/anatomopathologie , Tumeurs colorectales/étiologie , Maladies inflammatoires intestinales/complications , Maladies inflammatoires intestinales/diagnostic , Coloscopie/méthodes , Dépistage précoce du cancer/méthodes , Adénocarcinome/diagnostic , Adénocarcinome/anatomopathologie , Adénocarcinome/étiologie , Facteurs de risque
6.
Environ Res ; 252(Pt 2): 118889, 2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-38599452

RÉSUMÉ

BACKGROUND: The effects of long-term PM2.5 exposures since 1968 on adenocarcinoma lung cancer (AdLC) were not studied before. METHODS: This case-referent study used nationwide cancer registry data since 1997 and air pollution data since 1968 in Taiwan to estimate risks of 30-year PM2.5 exposures on AdLC. Cases were all AdLC, while references were all non-AdLC. Individuals' 30-year PM2.5 exposures were estimated by PM2.5 levels at their residence for 30 years prior their diagnosis dates. We applied multiple logistic regression analyses to estimate PM2.5 exposures on incidence rate ratios (IRRs) between cases and references, adjusting for sex, age, smoking, cancer stage, and EGFR mutation. RESULTS: Elevation in annual ambient PM2.5 concentrations since 1968 were associated with increase in annual age-adjusted AdLC incidence since 1997. AdLC incidences were higher among females, nonsmokers, the elderly aged above 65, cases of stages IIIB to IV, and EGFR mutation. Study subjects' PM2.5 exposures averaged at 33.7 ± 7.4 µg/m3 with 162 ± 130 high PM2.5 pollution days over 30 years. Multiple logistic models showed an increase in 10 µg/m3 of PM2.5 exposures were significantly associated with 1.044 of IRR between all AdLC and all non-AdLC cases during 2011-2020. Our models also showed that females and nonsmokers and adults less than 65 years had higher IRRs than their respective counterparts. Restricted analyses showed similar effects of PM2.5 exposures on IRRs between stage 0-IIIA and IIIB-IV cases and between EGFR+ and EGFR- cases. CONCLUSIONS: Long-term exposures to PM2.5 over 30 years were associated with elevated risks of AdLC against non-AdLC, regardless of gender, age, smoking status, cancer stage, or EGFR mutation.


Sujet(s)
Adénocarcinome pulmonaire , Exposition environnementale , Tumeurs du poumon , Matière particulaire , Humains , Taïwan/épidémiologie , Mâle , Femelle , Matière particulaire/toxicité , Matière particulaire/analyse , Tumeurs du poumon/épidémiologie , Tumeurs du poumon/induit chimiquement , Tumeurs du poumon/étiologie , Sujet âgé , Adulte d'âge moyen , Adénocarcinome pulmonaire/épidémiologie , Exposition environnementale/effets indésirables , Adulte , Adénocarcinome/épidémiologie , Adénocarcinome/étiologie , Adénocarcinome/induit chimiquement , Polluants atmosphériques/toxicité , Polluants atmosphériques/analyse , Incidence , Études cas-témoins , Sujet âgé de 80 ans ou plus
7.
J Gastroenterol Hepatol ; 39(8): 1580-1585, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38641971

RÉSUMÉ

BACKGROUND AND AIM: Since the first report of gastric adenocarcinoma of the fundic-gland type in 2010, the clinicopathological characteristics of gastric neoplasm of the fundic-gland type (GNFG) have become clearer; however, their risk factors remain unclear. This exploratory study aimed to identify the risk factors for GNFG. METHODS: We conducted a single-center, retrospective, matched case-control study using medical information recorded at our health management center from January 2014 to July 2023. During this period, 39 240 people underwent upper gastrointestinal endoscopy. GNFG were extracted as cases and matched to controls, according to age and sex, in a 1:8 ratio, excluding those with a history of gastrointestinal surgery and those with a history or comorbidity of cancer. Univariate analysis was used to compare patient background and endoscopic findings. Multivariable analysis was performed, adjusting for factors with P values < 0.1 and antacid use. RESULTS: A total of 20 GNFG cases and 160 matched healthy controls were included. In the univariate analysis, only reflux esophagitis was significantly more common in GNFG (40.0% vs 18.1%; P = 0.036). Factors antacids and duodenitis had P values < 0.1. Logistic regression analysis was performed, adjusting for antacids, reflux esophagitis, and duodenitis. Antacids and reflux esophagitis were the independent risk factors for GNFG (odds ratio = 3.68 [95% confidence interval: 1.04-11.91] and 3.25 [95% confidence interval: 1.11-9.35]). CONCLUSIONS: Although the sample of patients with GNFG was small, antacids and reflux esophagitis were identified as a risk factor. The pathogenesis of antacids and reflux esophagitis may be involved in the development of GNFG.


Sujet(s)
Antiacides gastriques , Oesophagite peptique , Tumeurs de l'estomac , Humains , Antiacides gastriques/usage thérapeutique , Facteurs de risque , Études rétrospectives , Études cas-témoins , Mâle , Tumeurs de l'estomac/épidémiologie , Tumeurs de l'estomac/étiologie , Femelle , Oesophagite peptique/épidémiologie , Oesophagite peptique/étiologie , Adulte d'âge moyen , Sujet âgé , Adénocarcinome/étiologie , Adénocarcinome/épidémiologie , Fundus gastrique/anatomopathologie , Adulte
8.
J Gastrointest Surg ; 28(4): 337-342, 2024 Apr.
Article de Anglais | MEDLINE | ID: mdl-38583881

RÉSUMÉ

BACKGROUND: The relationship among obesity, bariatric surgery, and esophageal adenocarcinoma (EAC) is complex, given that some bariatric procedures are thought to be associated with increased incidence of reflux and Barrett's esophagus. Previous bariatric surgery may complicate the use of the stomach as a conduit for esophagectomy. In this study, we presented our experience with patients who developed EAC after bariatric surgery and described the challenges encountered and the techniques used. METHODS: We conducted a retrospective review of our institutional database to identify all patients at our institution who were treated for EAC after previously undergoing bariatric surgery. RESULTS: In total, 19 patients underwent resection with curative intent for EAC after bariatric surgery, including 10 patients who underwent sleeve gastrectomy. The median age at diagnosis of EAC was 63 years; patients who underwent sleeve gastrectomy were younger (median age, 56 years). The median time from bariatric surgery to EAC was 7 years. Most patients had a body mass index (BMI) score of >30 kg/m2 at the time of diagnosis of EAC; approximately 40% had class III obesity (BMI score > 40 kg/m2). Six patients (32%) had known Barrett's esophagus before undergoing a reflux-increasing bariatric procedure. Sleeve gastrectomy patients underwent esophagectomy with gastric conduit, colonic interposition, or esophagojejunostomy. Only 1 patient had an anastomotic leak (after esophagojejunostomy). CONCLUSION: Endoscopy should be required both before (for treatment selection) and after all bariatric surgical procedures. Resection of EAC after bariatric surgery requires a highly individualized approach but is safe and feasible.


Sujet(s)
Adénocarcinome , Chirurgie bariatrique , Oesophage de Barrett , Tumeurs de l'oesophage , Reflux gastro-oesophagien , Obésité morbide , Humains , Adulte d'âge moyen , Oesophage de Barrett/étiologie , Oesophage de Barrett/chirurgie , Oesophage de Barrett/diagnostic , Tumeurs de l'oesophage/étiologie , Tumeurs de l'oesophage/chirurgie , Tumeurs de l'oesophage/diagnostic , Adénocarcinome/étiologie , Adénocarcinome/chirurgie , Adénocarcinome/diagnostic , Chirurgie bariatrique/effets indésirables , Reflux gastro-oesophagien/chirurgie , Reflux gastro-oesophagien/complications , Obésité/complications , Obésité/chirurgie , Gastrectomie/effets indésirables , Études rétrospectives , Obésité morbide/chirurgie
9.
Eur J Nutr ; 63(5): 1413-1424, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-38689010

RÉSUMÉ

PURPOSE: This updated umbrella review aimed to evaluate the evidence regarding the associations between dietary factors and the risks of esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC). METHODS: The PubMed, Embase, Cochrane Library, and Web of Science databases were searched to identify relevant studies. The quality of the included meta-analyses was evaluated using A MeaSurement Tool to Assess systematic Reviews 2 (AMSTAR 2). For each association, the number of cases, random effects pooled effect size, 95% confidence intervals (CIs), heterogeneity, 95% prediction interval (PrI), small-study effect, and excess significance bias were recalculated to determine the evidence level. RESULTS: We identified 33 meta-analyses describing 58 dietary factors associated with ESCC and 29 meta-analyses describing 38 dietary factors associated with EAC. There was convincing evidence regarding the association of 2 dietary factors (areca nut and high alcohol) with the risk of ESCC. There was highly suggestive evidence regarding the association of only 1 dietary factor (healthy pattern) with the risk of ESCC. There was suggestive evidence regarding the association of 11 dietary factors with the risk of ESCC, including fruit, citrus fruit, vegetables, pickled vegetables, maté tea, moderate alcohol, hot beverages and foods, hot tea, salt, folate, and vitamin B6. There was convincing evidence regarding the association of one dietary factor (vitamin B6) with the risk of EAC. There was suggestive evidence regarding the association of 4 dietary factors with the risk of EAC, including processed meat, dietary fibre, carbohydrate, and vitamin B12. The convincing evidence regarding the associations between dietary factors and the risks of ESCC and EAC remained robust in sensitivity analyses. CONCLUSIONS: This umbrella review highlighted convincing evidence regarding the associations of areca nut and high alcohol with a higher risk of ESCC. Additionally, an association between vitamin B6 and a decreased risk of EAC was observed. Further research is needed to examine the dietary factors with weak evidence regarding their associations with ESCC and EAC.


Sujet(s)
Adénocarcinome , Régime alimentaire , Tumeurs de l'oesophage , Carcinome épidermoïde de l'oesophage , Humains , Tumeurs de l'oesophage/épidémiologie , Tumeurs de l'oesophage/étiologie , Régime alimentaire/méthodes , Régime alimentaire/statistiques et données numériques , Régime alimentaire/effets indésirables , Adénocarcinome/étiologie , Adénocarcinome/épidémiologie , Carcinome épidermoïde de l'oesophage/épidémiologie , Carcinome épidermoïde de l'oesophage/étiologie , Facteurs de risque , Carcinome épidermoïde/épidémiologie , Carcinome épidermoïde/étiologie
11.
Nihon Shokakibyo Gakkai Zasshi ; 121(4): 315-320, 2024.
Article de Japonais | MEDLINE | ID: mdl-38599842

RÉSUMÉ

An 89-year-old man was diagnosed with a submucosal tumor suspected to be a lipoma and was followed up for 6 years. The patient was admitted to the hospital because of increased tumor size and morphological changes despite negative bioptic findings. The lesion was diagnosed as an advanced adenocarcinoma of the ascending colon (cT3N0M0, cStage IIa). Laparoscopic-assisted right hemicolectomy with D3 lymph node dissection was performed. Pathological diagnosis of a surgically resected specimen revealed adenocarcinoma with lipohyperplasia (pT3N2aM0, pStage IIIb). Reports of colon cancer accompanied by colonic lipomas or lipohyperplasia are limited. This case showed an interesting submucosal tumor-like morphology because the cancer developed at the base of the lipohyperplasia and grew and spread below it.


Sujet(s)
Adénocarcinome , Tumeurs du côlon , Mâle , Humains , Sujet âgé de 80 ans ou plus , Côlon ascendant/anatomopathologie , Côlon ascendant/chirurgie , Tumeurs du côlon/imagerie diagnostique , Tumeurs du côlon/étiologie , Tumeurs du côlon/chirurgie , Iléum , Adénocarcinome/imagerie diagnostique , Adénocarcinome/étiologie , Adénocarcinome/chirurgie , Hyperplasie/complications , Hyperplasie/anatomopathologie
12.
Obes Surg ; 34(5): 1726-1736, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38536625

RÉSUMÉ

PURPOSE: This study aims to systematically review and meta-analyze the evidence on the risk of esophageal adenocarcinoma (EAC) following metabolic and bariatric surgery (MBS). MATERIALS AND METHODS: A systematic literature search was conducted on the China National Knowledge Infrastructure (CNKI), Wanfang, EMBASE, MEDLINE, Web of Science, The Cochrane Library, and PubMed databases. Meta-analysis utilized odds ratios (ORs) and 95% confidence intervals (CIs) to analyze the correlation between MBS and the risk of EAC. Meta-analysis was performed using STATA software (version 12.0). RESULTS: Fourteen studies involving patients with obesity undergoing bariatric surgery and control groups receiving conventional treatment were included. The meta-analysis indicated a reduction in the overall incidence of esophageal cancer after bariatric surgery (OR = 0.69, 95% CI: 0.51-0.95, P = 0.022). Subgroup analysis results demonstrated a decreased risk of EAC in European patients with obesity undergoing MBS treatment (OR: 0.60, 95% CI: 0.38-0.95, P = 0.028). In studies with a sample size greater than or equal to 100,000 patients, the risk of EAC in patients with obesity undergoing MBS was significantly lower than the non-surgery group (OR: 0.59, 95% CI: 0.42-0.83, P = 0.003). Articles published before 2020 and those published in 2020 or earlier showed a significant difference in the incidence of EAC between the surgery and non-surgery groups (OR: 0.57, 95% CI: 0.43-0.75, P < 0.001). The risk of EAC in patients with obesity with a follow-up time of less than 5 years was statistically significant (OR: 0.46, 95% CI: 0.25-0.82, P = 0.009). CONCLUSION: Our meta-analysis results suggest a reduced risk of esophageal cancer in patients with obesity after bariatric surgery. PROSPERO REGISTRATION: CRD 42024505177.


Sujet(s)
Adénocarcinome , Chirurgie bariatrique , Tumeurs de l'oesophage , Humains , Tumeurs de l'oesophage/épidémiologie , Tumeurs de l'oesophage/chirurgie , Adénocarcinome/épidémiologie , Adénocarcinome/chirurgie , Adénocarcinome/étiologie , Études rétrospectives , Obésité morbide/chirurgie , Obésité morbide/complications , Incidence , Femelle , Facteurs de risque , Mâle , Adulte d'âge moyen , Adulte , Chine/épidémiologie , Obésité/complications
13.
Dis Colon Rectum ; 67(S1): S91-S98, 2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38422398

RÉSUMÉ

BACKGROUND: IPAA is often required for patients with ulcerative colitis or familial adenomatous polyposis after colectomy. This procedure reduces but does not completely eliminate the risk of neoplasia. OBJECTIVE: This study focuses on the histopathology of neoplasia in the ileal pouch, rectal cuff, and anal transition zone. DATA SOURCES: We performed a MEDLINE search for English-language studies published between 1981 and 2022 using the PubMed search engine. The terms "ileal pouch-anal anastomosis," "pouchitis," "pouch dysplasia," "pouch lymphoma," "pouch squamous cell carcinoma," "pouch adenocarcinoma," "pouch neoplasia," "dysplasia of rectal cuff," and "colitis-associated dysplasia" were used. STUDY SELECTION: Human studies of neoplasia occurring in the pouch and para-pouch were selected, and the full text was reviewed. Comparisons were made within and across studies, with key concepts selected for inclusion in this article. CONCLUSIONS: Neoplasia in the pouch is a rare complication in patients with IPAA. Annual endoscopic surveillance is recommended for familial adenomatous polyposis patients and ulcerative colitis patients with a history of prior dysplasia or carcinoma. In familial adenomatous polyposis, dysplastic polyps of the pouch are visible and readily amenable to endoscopic removal; however, glandular dysplasia in the setting of ulcerative colitis may be invisible on endoscopy. Therefore, random biopsies and adequate tissue sampling of the pouch and rectal cuff are recommended in this setting. The histological diagnosis of IBD-associated dysplasia can be challenging and should be confirmed by at least 1 expert GI pathologist. See video from the symposium.


Sujet(s)
Polypose adénomateuse colique , Poches coliques , Proctocolectomie restauratrice , Humains , Polypose adénomateuse colique/anatomopathologie , Polypose adénomateuse colique/chirurgie , Polypose adénomateuse colique/complications , Poches coliques/effets indésirables , Poches coliques/anatomopathologie , Proctocolectomie restauratrice/effets indésirables , Rectocolite hémorragique/anatomopathologie , Rectocolite hémorragique/complications , Rectocolite hémorragique/chirurgie , Pochite/anatomopathologie , Pochite/étiologie , Pochite/diagnostic , Adénocarcinome/anatomopathologie , Adénocarcinome/étiologie , Adénocarcinome/chirurgie , Maladies inflammatoires intestinales/anatomopathologie , Maladies inflammatoires intestinales/complications
14.
Int J Cancer ; 154(11): 1920-1929, 2024 Jun 01.
Article de Anglais | MEDLINE | ID: mdl-38339891

RÉSUMÉ

Esophageal cancer (EC), which includes squamous cell carcinoma (ESCC) and adenocarcinoma (EAC), is an important cancer with poor prognosis and high mortality rate. Several occupational exposures have been associated with EC. We aim to investigate the association between occupational asbestos exposure and EC risk, considering types of asbestos and histology of the disease. We included studies mentioned in the list of references in previous reviews and pooled analyses, and we conducted an independent search in PubMed and Scopus. Forest plots of relative risks (RR) were constructed based on the association between occupational asbestos and EC risk. Random-effects models were used to address heterogeneity between 48 independent cohort and case-control studies. We found an association between occupational asbestos exposure and EC (meta-relative risk [RR] = 1.20, 95% confidence interval [CI] = 1.09-1.32; I2 = 58.8%, p-heterogeneity [het] <.001). The results of stratification by job (p-het = .20) indicate an increased RR among asbestos product workers (RR = 1.39, 95% CI = 1.07-1.81), asbestos applicators (RR = 1.41, 95% CI = 1.20-1.67), and construction workers (RR = 1.12, 95% CI = 1.02-1.24). There was no heterogeneity in meta-RR according to outcome (p = .29), geographic region (p = .69), year of publication (p = .59), quality score (p = .73), asbestos type (p = .93), study design (p = .87), and gender (p = .88), control for potential confounders (p = .20), year of first employment (p = .94) and exposure level (p = .43). The stratification analysis by histology type found an increased RR for both ESCC 1.33(1.03-1.71) and EAC 1.45(1.03-2.04) (p-het = .68). We didn't find evidence of publication bias (p = .07). The results of our study suggest that occupational asbestos exposure is associated with an increased risk of EC in both histology types.


Sujet(s)
Amiante , Tumeurs de l'oesophage , Exposition professionnelle , Humains , Exposition professionnelle/effets indésirables , Tumeurs de l'oesophage/étiologie , Tumeurs de l'oesophage/épidémiologie , Amiante/effets indésirables , Facteurs de risque , Études cas-témoins , Mâle , Adénocarcinome/étiologie , Adénocarcinome/épidémiologie , Femelle
15.
J Gastroenterol Hepatol ; 39(5): 893-901, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-38273469

RÉSUMÉ

BACKGROUND AND AIM: Colitis-associated intestinal cancer (CAC) can develop in patients with inflammatory bowel disease; however, the malignant grade of CAC may differ from that of sporadic colorectal cancer (CRC). Therefore, we compared histological findings distinct from cancer stage between CAC and sporadic CRC to evaluate the features of CAC. METHODS: We reviewed the clinical and histological data collected from a nationwide database in Japan between 1983 and 2020. Patient characteristics were compared to distinguish ulcerative colitis (UC), Crohn's disease (CD), and sporadic CRC. Comparisons were performed by using all collected data and propensity score-matched data. RESULTS: A total of 1077 patients with UC-CAC, 297 with CD-CAC, and 136 927 with sporadic CRC were included. Although the prevalence of well or moderately differentiated adenocarcinoma (Tub1 and Tub2) decreased according to tumor progression for all diseases (P < 0.01), the prevalence of other histological findings, including signet ring cell carcinoma, mucinous carcinoma, poorly differentiated adenocarcinoma, or squamous cell carcinoma, was significantly higher in CAC than in sporadic CRC. Based on propensity score-matched data for 982 patients with UC and 268 with CD, the prevalence of histological findings other than Tub1 and Tub2 was also significantly higher in those with CAC. At pT4, mucinous carcinoma occurred at a significantly higher rate in patients with CD (45/86 [52.3%]) than in those with sporadic CRC (13/88 [14.8%]) (P < 0.01). CONCLUSION: CAC, including early-stage CAC, has a higher malignant grade than sporadic CRC, and this difference increases in significance with tumor progression.


Sujet(s)
Rectocolite hémorragique , Score de propension , Humains , Mâle , Femelle , Adulte d'âge moyen , Rectocolite hémorragique/anatomopathologie , Rectocolite hémorragique/complications , Rectocolite hémorragique/épidémiologie , Sujet âgé , Japon/épidémiologie , Maladie de Crohn/anatomopathologie , Maladie de Crohn/épidémiologie , Maladie de Crohn/complications , Néoplasmes associés aux colites/anatomopathologie , Néoplasmes associés aux colites/étiologie , Néoplasmes associés aux colites/épidémiologie , Tumeurs colorectales/anatomopathologie , Tumeurs colorectales/épidémiologie , Tumeurs colorectales/étiologie , Adulte , Adénocarcinome/anatomopathologie , Adénocarcinome/épidémiologie , Adénocarcinome/étiologie , Stadification tumorale , Grading des tumeurs , Adénocarcinome mucineux/anatomopathologie , Adénocarcinome mucineux/épidémiologie , Adénocarcinome mucineux/étiologie , Carcinome à cellules en bague à chaton/anatomopathologie , Carcinome à cellules en bague à chaton/épidémiologie , Carcinome épidermoïde/anatomopathologie , Carcinome épidermoïde/épidémiologie , Carcinome épidermoïde/étiologie , Diagnostic différentiel , Prévalence
16.
J Gastroenterol ; 59(3): 187-194, 2024 03.
Article de Anglais | MEDLINE | ID: mdl-38263336

RÉSUMÉ

BACKGROUND: Patients with familial adenomatous polyposis (FAP) have an increased risk of developing gastric neoplasms. However, the clinical course of FAP with these gastric lesions has not yet been fully clarified. The present study aimed to clarify the changes in the incidence risk of developing gastric adenoma or gastric cancer during the lifespan of patients with FAP. METHODS: Four hundred forty-three patients with data regarding gastric adenoma and gastric cancer retrospectively registered in a nationwide Japanese multicenter study were enrolled. The cumulative incidences and hazard rates (HRs) of gastric neoplasms were evaluated. RESULTS: The cumulative incidence rates in 50-year-old patients with FAP were 22.8% for gastric adenoma and 7.6% for gastric cancer, respectively. No significant association was found between gastric neoplasms and the colonic phenotype. The peak age for the HR of gastric adenoma was 65 years, with the highest HR (0.043). Regarding the incidence of gastric cancer, the HR increased moderately up to the age of 40 years, but the increase accelerated from the age of 50 years (HR = 0.0067). CONCLUSION: Careful surveillance of the upper gastrointestinal tract in elderly patients with FAP, such as shortening the interval of follow-up according to age, may be helpful for early diagnosis of gastric cancer.


Sujet(s)
Adénocarcinome , Polypose adénomateuse colique , Polypes adénomateux , Tumeurs de l'estomac , Humains , Sujet âgé , Adulte , Adulte d'âge moyen , Tumeurs de l'estomac/étiologie , Tumeurs de l'estomac/génétique , Japon/épidémiologie , Polypose adénomateuse colique/complications , Polypose adénomateuse colique/épidémiologie , Polypose adénomateuse colique/génétique , Adénocarcinome/épidémiologie , Adénocarcinome/étiologie , Adénocarcinome/anatomopathologie
17.
Acta Chir Belg ; 124(2): 143-146, 2024 Apr.
Article de Anglais | MEDLINE | ID: mdl-37668063

RÉSUMÉ

Crohn's disease patients frequently develop perianal fistulas during their life. They are also at higher risk to develop cancers. Rarely, those cancers appear within a prior chronic fistula. The main types are adenocarcinoma mostly mucinous and squamous cell carcinoma. They are generally discovered at an advanced stage with a poor prognosis because symptoms are generally the same as those of the fistula itself. Regular follow-up of chronic fistulas is then important for an early diagnosis as well as histological analysis of the fistula during surgery. There is no consensus on the ideal treatment but abdominoperineal resection is the corner stone with or without neo or adjuvant chemo-radiotherapy. This paper presents a rare case of mucinous adenocarcinoma in a chronic perianal fistula in a Crohn's disease female and provides a review of the literature.


Sujet(s)
Adénocarcinome mucineux , Adénocarcinome , Carcinome épidermoïde , Maladie de Crohn , Fistule rectale , Humains , Femelle , Maladie de Crohn/complications , Maladie de Crohn/chirurgie , Fistule rectale/diagnostic , Fistule rectale/étiologie , Fistule rectale/thérapie , Adénocarcinome/étiologie , Adénocarcinome/chirurgie , Adénocarcinome/anatomopathologie , Adénocarcinome mucineux/complications , Adénocarcinome mucineux/diagnostic , Carcinome épidermoïde/diagnostic , Carcinome épidermoïde/étiologie , Carcinome épidermoïde/chirurgie
18.
Am J Respir Crit Care Med ; 209(3): 307-315, 2024 Feb 01.
Article de Anglais | MEDLINE | ID: mdl-37856832

RÉSUMÉ

Rationale: Particulate matter ⩽2.5 µm in aerodynamic diameter (PM2.5) is an established cause of lung cancer, but the association with ultrafine particulate matter (UFP; aerodynamic diameter < 0.1 µm) is unclear. Objectives: To investigate the association between UFP and lung cancer overall and by histologic subtype. Methods: The Los Angeles Ultrafines Study includes 45,012 participants aged ⩾50 years in southern California at enrollment (1995-1996) followed through 2017 for incident lung cancer (n = 1,770). We estimated historical residential ambient UFP number concentrations via land use regression and back extrapolation using PM2.5. In Cox proportional hazards models adjusted for smoking and other confounders, we estimated associations between 10-year lagged UFP (per 10,000 particles/cm3 and quartiles) and lung cancer overall and by major histologic subtype (adenocarcinoma, squamous cell carcinoma, and small cell carcinoma). We also evaluated relationships by smoking status, birth cohort, and historical duration at the residence. Measurements and Main Results: UFP was modestly associated with lung cancer risk overall (hazard ratio [HR], 1.03 [95% confidence interval (CI), 0.99-1.08]). For adenocarcinoma, we observed a positive trend among men; risk was increased in the highest exposure quartile versus the lowest (HR, 1.39 [95% CI, 1.05-1.85]; P for trend = 0.01) and was also increased in continuous models (HR per 10,000 particles/cm3, 1.09 [95% CI, 1.00-1.18]), but no increased risk was apparent among women (P for interaction = 0.03). Adenocarcinoma risk was elevated among men born between 1925 and 1930 (HR, 1.13 [95% CI, 1.02-1.26] per 10,000) but not for other birth cohorts, and was suggestive for men with ⩾10 years of residential duration (HR, 1.11 [95% CI, 0.98-1.26]). We found no consistent associations for women or other histologic subtypes. Conclusions: UFP exposure was modestly associated with lung cancer overall, with stronger associations observed for adenocarcinoma of the lung.


Sujet(s)
Adénocarcinome , Polluants atmosphériques , Pollution de l'air , Tumeurs du poumon , Mâle , Humains , Femelle , Sujet âgé , Matière particulaire/effets indésirables , Matière particulaire/analyse , Polluants atmosphériques/effets indésirables , Polluants atmosphériques/analyse , Tumeurs du poumon/épidémiologie , Tumeurs du poumon/étiologie , Californie/épidémiologie , Adénocarcinome/épidémiologie , Adénocarcinome/étiologie , Pollution de l'air/effets indésirables , Pollution de l'air/analyse , Exposition environnementale/effets indésirables , Exposition environnementale/analyse
19.
Eur J Nutr ; 63(2): 377-396, 2024 Mar.
Article de Anglais | MEDLINE | ID: mdl-37989797

RÉSUMÉ

PURPOSE: To investigate the role of adiposity in the associations between ultra-processed food (UPF) consumption and head and neck cancer (HNC) and oesophageal adenocarcinoma (OAC) in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. METHODS: Our study included 450,111 EPIC participants. We used Cox regressions to investigate the associations between the consumption of UPFs and HNC and OAC risk. A mediation analysis was performed to assess the role of body mass index (BMI) and waist-to-hip ratio (WHR) in these associations. In sensitivity analyses, we investigated accidental death as a negative control outcome. RESULTS: During a mean follow-up of 14.13 ± 3.98 years, 910 and 215 participants developed HNC and OAC, respectively. A 10% g/d higher consumption of UPFs was associated with an increased risk of HNC (hazard ratio [HR] = 1.23, 95% confidence interval [CI] 1.14-1.34) and OAC (HR = 1.24, 95% CI 1.05-1.47). WHR mediated 5% (95% CI 3-10%) of the association between the consumption of UPFs and HNC risk, while BMI and WHR, respectively, mediated 13% (95% CI 6-53%) and 15% (95% CI 8-72%) of the association between the consumption of UPFs and OAC risk. UPF consumption was positively associated with accidental death in the negative control analysis. CONCLUSIONS: We reaffirmed that higher UPF consumption is associated with greater risk of HNC and OAC in EPIC. The proportion mediated via adiposity was small. Further research is required to investigate other mechanisms that may be at play (if there is indeed any causal effect of UPF consumption on these cancers).


Sujet(s)
Adénocarcinome , Tumeurs de l'oesophage , Tumeurs de la tête et du cou , Humains , Adiposité , Études prospectives , Aliments transformés , Analyse de médiation , Obésité , Adénocarcinome/épidémiologie , Adénocarcinome/étiologie , Aliments de restauration rapide/effets indésirables , Régime alimentaire , Manipulation des aliments
20.
J Pediatr Hematol Oncol ; 46(1): e94-e99, 2024 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-37878545

RÉSUMÉ

Esophageal carcinoma in children and adolescents is extremely rare. Here, we report 2 cases of pediatric esophageal carcinoma presenting with progressive dysphagia. There was not any underlying specific risk factor in our cases. The histopathological subtypes were adenocarcinoma in one and squamous cell carcinoma in another case. Response to combined modality treatment was good in the case of adenocarcinoma, while the patient with squamous cell carcinoma was unresponsive to treatment and died of the progressive disease. We reviewed the pediatric cases of esophageal carcinoma reported in the literature. Progressive dysphagia was observed in 89% of these cases. One third of pediatric cases had underlying risk factors. Squamous cell carcinoma is a more common type of childhood esophageal carcinoma. In contrast to adults, pediatric esophageal squamous cell carcinoma may distribute throughout the esophagus. Esophageal adenocarcinoma was seen in the distal esophagus in pediatric cases. Metastatic disease was found in 48% of pediatric patients at presentation, and the prognosis is poor. Collaborative efforts are needed for success in the treatment of esophageal carcinoma.


Sujet(s)
Adénocarcinome , Carcinome épidermoïde , Troubles de la déglutition , Tumeurs de l'oesophage , Carcinome épidermoïde de l'oesophage , Adulte , Adolescent , Humains , Enfant , Tumeurs de l'oesophage/thérapie , Tumeurs de l'oesophage/anatomopathologie , Carcinome épidermoïde/anatomopathologie , Adénocarcinome/étiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE